BioSpace Releases 2013 Pharm Country Economic Outlook Report Hotbed region of Connecticut, New York, New Jersey, and Pennsylvania ranks 3rd in national hiring.
DENVER, April 10, 2013 /PRNewswire/ -- Today BioSpace, the largest online source for biotech and life sciences job search, recruitment solutions and news, released its inaugural BioSpace Economic Outlook Report: Pharm Country with a look at hiring trends, salary figures, and more.
For more than a decade, BioSpace has been highlighting life sciences / biotech in the Pharm Country region with the Pharm Country Hotbed map. The map highlights organizations that comprise biotech, pharmaceutical, and the medical device community in the Connecticut, New York, New Jersey, and Pennsylvania area. To honor the 13th edition, which launches in June, BioSpace developed the report that examines Pharm Country's economic outlook.
"Pharm Country continues to be a leading life sciences hotbed region as number three in U.S. hiring," said Tricia Pattee, BioSpace Product Manager. "In fact, if the numbers that we see continue, it could move into the number two spot in 2013."
Learn about the current state of life sciences / biotechnology careers, including top jobs, salary information and positions such as Clinical Research, Scientists, Regulatory Affairs, Quality Assurance / Quality Control, Research Associates, and more by downloading BioSpace Economic Outlook Report: Pharm Country.
Are you a leading life sciences / biotech organization in Pharm Country? Click here to learn more about how to participate in the map campaign.
BioSpace.com is the largest online source for biotech and life sciences jobs, recruitment solutions and news. For 25 years, BioSpace has helped accelerate recruitment, communication, and discovery among business and scientific leaders within life sciences. An onTargetjobs, Inc. company, BioSpace powers DeviceSpace.com, an information and recruitment resource for the medical device and diagnostics industries, as well as ClinicaSpace.com, a similar resource for clinical research markets.